154 related articles for article (PubMed ID: 28051255)
21. Long non-coding RNA MVIH is associated with poor prognosis and malignant biological behavior in breast cancer.
Lei B; Xu SP; Liang XS; Li YW; Zhang JF; Zhang GQ; Pang D
Tumour Biol; 2016 Apr; 37(4):5257-64. PubMed ID: 26555546
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity in bladder cancer cells.
Feng SQ; Zhang XY; Fan HT; Sun QJ; Zhang M
Neoplasma; 2018 Nov; 65(6):925-932. PubMed ID: 29940769
[TBL] [Abstract][Full Text] [Related]
23. High expression of long noncoding RNA Sox2ot is associated with the aggressive progression and poor outcome of gastric cancer.
Zou JH; Li CY; Bao J; Zheng GQ
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4482-4486. PubMed ID: 27874951
[TBL] [Abstract][Full Text] [Related]
24. Decreased CDK10 expression correlates with lymph node metastasis and predicts poor outcome in breast cancer patients - a short report.
You Y; Li H; Qin X; Zhang Y; Song W; Ran Y; Gao F
Cell Oncol (Dordr); 2015 Dec; 38(6):485-91. PubMed ID: 26392360
[TBL] [Abstract][Full Text] [Related]
25. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
Michaelidou K; Ardavanis A; Scorilas A
Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
[TBL] [Abstract][Full Text] [Related]
26. Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer.
Duan W; Du L; Jiang X; Wang R; Yan S; Xie Y; Yan K; Wang Q; Wang L; Zhang X; Pan H; Yang Y; Wang C
Oncotarget; 2016 Nov; 7(48):78850-78858. PubMed ID: 27793008
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway.
Zhang CY; Yu MS; Li X; Zhang Z; Han CR; Yan B
Tumour Biol; 2017 Jun; 39(6):1010428317701311. PubMed ID: 28635399
[TBL] [Abstract][Full Text] [Related]
28. TMPRSS3 is a novel poor prognostic factor for breast cancer.
Rui X; Li Y; Jin F; Li F
Int J Clin Exp Pathol; 2015; 8(5):5435-42. PubMed ID: 26191247
[TBL] [Abstract][Full Text] [Related]
29. Prognostic and biological significance of microRNA-127 expression in human breast cancer.
Wang S; Li H; Wang J; Wang D; Yao A; Li Q
Dis Markers; 2014; 2014():401986. PubMed ID: 25477702
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters.
Záveský L; Jandáková E; Weinberger V; Minář L; Kohoutová M; Slanař O
Cancer Biomark; 2024; 40(1):61-78. PubMed ID: 38277283
[TBL] [Abstract][Full Text] [Related]
31. Prognostic and biological significance of microRNA-221 in breast cancer.
Eissa S; Matboli M; Sharawy A; El-Sharkawi F
Gene; 2015 Dec; 574(1):163-7. PubMed ID: 26253160
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of lncRNA-ATB correlates with clinical progression and unfavorable prognosis in pancreatic cancer.
Qu S; Yang X; Song W; Sun W; Li X; Wang J; Zhong Y; Shang R; Ruan B; Zhang Z; Zhang X; Li H
Tumour Biol; 2016 Mar; 37(3):3933-8. PubMed ID: 26482611
[TBL] [Abstract][Full Text] [Related]
33. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of long noncoding RNA LINC01296 indicates an unfavorable prognosis and promotes tumorigenesis in breast cancer.
Jiang M; Xiao Y; Liu D; Luo N; Gao Q; Guan Y
Gene; 2018 Oct; 675():217-224. PubMed ID: 29981416
[TBL] [Abstract][Full Text] [Related]
36. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
37. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
Dong LL; Chen LM; Wang WM; Zhang LM
Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA Loc554202 expression as a prognostic factor in patients with colorectal cancer.
Yang L; Wei H; Xiao HJ
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4243-4247. PubMed ID: 27831651
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA MEG3 as a candidate prognostic factor for induction therapy response and survival profile in childhood acute lymphoblastic leukemia patients.
Gao W
Scand J Clin Lab Invest; 2021 May; 81(3):194-200. PubMed ID: 33600264
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of long noncoding RNA MEG3 expression in the survival of patients with cancer: A meta-analysis.
Binabaj MM; Bahrami A; Bahreyni A; Shafiee M; Rahmani F; Khazaei M; Soleimanpour S; Ghorbani E; Fiuji H; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
J Cell Biochem; 2018 Nov; 119(11):9583-9590. PubMed ID: 30129051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
